Precision BioSciences
DTIL
43 hedge funds and large institutions have $42.8M invested in Precision BioSciences in 2024 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 32 closing their positions.
234% more capital invested
Capital invested by funds: $12.8M → $42.8M (+$30M)
19.41% more ownership
Funds ownership: 28.83% → 48.23% (+19%)
14% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 14
34% less funds holding
Funds holding: 65 → 43 (-22)
69% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 32
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
+$7.01M |
| 2 |
PA
Perceptive Advisors
New York
|
+$5.88M |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
+$5.83M |
| 4 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$4.72M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$3.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$1.87M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$223K |
| 3 |
Two Sigma Advisers
New York
|
-$183K |
| 4 |
Goldman Sachs
New York
|
-$180K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$143K |
DTIL Hedge Fund Activity: Q1 2024 in Review
43 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q1 2024, worth a combined $42.8M — up 234% from $12.8M a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of DTIL and 10 opened new positions — a net loss of 22 holders — while 14 trimmed existing stakes and 12 added.
The largest buyer was Janus Henderson Group, opening a new position worth an estimated $7.01M. The largest seller was Capital World Investors, exiting entirely with an estimated $1.87M sold.
- 43 institutional investors held Precision BioSciences (DTIL) as of Q1 2024, down from 65 in Q4 2023.
- Funds reported $42.8M of Precision BioSciences stock for Q1 2024, up 234% quarter-over-quarter.
- 10 funds opened new Precision BioSciences positions in Q1 2024 and 32 closed out, a net change of -22 holders.
- The largest Precision BioSciences buyer in Q1 2024 was Janus Henderson Group, an estimated $7.01M added.
- The largest Precision BioSciences seller in Q1 2024 was Capital World Investors, an estimated $1.87M sold.
Based on aggregated 13F filings for Q1 2024.